Specialization
cardio-kidney-metabolic (CKM) disease, peritoneal dialysis, hemodialysis, sodium-glucose co-transporter 2 inhibition (SGLT2i), cardiovascular risk management in CKD and kidney failure
Focus of research
cardio-kidney-metabolic (CKM) disease, chronic kidney disease (CKD), heart failure in CKD, sodium-glucose co-transporter 2 inhibition (SGLT2i), kidney failure, peritoneal dialysis, hemodialysis